Pharmaceutical Executive November 19, 2024
Gaugarin Oliver

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

The AI rush is on in pharma organizations. A recent report by McKinsey & Company estimates up to $110 billion annual potential1 across 21 pharma use cases in R&D, clinical development, operations, commercial, and medical affairs. But how do executives feel about where AI is taking us, when results will arrive, and how organizations will get there?

New data2 from a September 2024 report by our company show that an impressive 91% of life science executives say they believe in AI’s value (Figure 1), with only 7% reporting skepticism.

What’s more, pharma leaders are putting their beliefs into action. Three out of four respondents were either...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
OpenAI’s GPT-5 Model Reportedly Behind Schedule With Uncertain Future
10 AI Predictions For 2025
Three Practical Reasons To Consider AI Agents For Your Organization
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
My Medical AI Holiday Wish List

Share This Article